A man in his 70s was admitted to an intensive care unit with severe COVID-19 and treated with dexamethasone and tocilizumab. After recovery from COVID-19, he developed bacteraemia and non-occlusive mesenteric ischaemia, with fatal outcome. He had been prescribed MIYAIRI 588 fine granules as probiotics for a month. The genome sequences of the isolate from the blood culture and MIYAIRI 588 fine granules were identical by single nucleotide polymorphism analysis. This is the first case of definitive probiotics-related bacteraemia after treatment of severe COVID-19.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/bcr-2024-261578 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Probiotics-related bacteraemia after COVID-19, confirmed by whole-genome sequencing.
BMJ Case Rep
August 2024
Infectious Disease, Fujita Health Universitiy Hospital, Toyoake, Aichi, Japan.
A man in his 70s was admitted to an intensive care unit with severe COVID-19 and treated with dexamethasone and tocilizumab. After recovery from COVID-19, he developed bacteraemia and non-occlusive mesenteric ischaemia, with fatal outcome. He had been prescribed MIYAIRI 588 fine granules as probiotics for a month.
View Article and Find Full Text PDFBacteraemia Caused by Probiotic Strains of -Case Studies Highlighting the Need for Careful Thought before Using Microbes for Health Benefits.
Pathogens
August 2022
Department of Microbiology, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-094 Bydgoszcz, Poland.
Lactic acid bacteria belonging to spp. and spp. are a natural part of fermented milk and other food products, probiotic supplements and human microbiota.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!